Frontlight ResearchEarly access
Active, not recruitingNo phase
A Study to Investigate the Clinical Outcome and Quality of Life in Chinese Post-operative CRSwNP Patients
Key facts
- Who runs it
- AstraZeneca
- Where
- China18 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 146 people enrolled
- Started
- 19 Mar 2026
- Expected to end
- 21 Oct 2027
- Type of study
- Observational
- Treatments tested
- Other: Routine Clinical Care for CRSwNP
- Record updated
- 25 September 2026
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (9)Hide the full registry criteria
Who can take part
- Participant must be 16 years of age or older, at the time of signing the informed consent
- Participants with a documented diagnosis of bilateral CRSwNP
- ESS is performed during the screening period
- Voluntarily participate and sign the ICF
- No history or current psychiatric disorders, with normal cognitive functions including understanding, expression, and orientation
Who cannot take part
- Use of biologic therapy for CRSwNP within 3 months prior to surgery
- Any significant disease or disorder that the investigator believes may place the patient at risk or may affect the study results or the patient's ability to participate in the study
- Currently participating in an interventional study
- Patients who are unable to independently complete questionnaires due to language barriers or mental status
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This is a prospective, multicenter real-world observational study designed to describe post-operative outcomes, quality of life, disease control, recurrence-related characteristics, economic burden and post-operative treatment patterns in Chinese patients with CRSwNP undergoing endoscopic sinus surgery (ESS).
The group in the trial
- CRSwNP Registry Cohort
This is a prospective, multicenter real-world observational study .Patients will receive standard medical care as determined by the treating physician according to routine clinical practice at each site. No treatment assignment will be made as part of the study.
Treatment: Other: Routine Clinical Care for CRSwNP
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- PREDICT: A Prospective, Multicenter Real-World Study to Describe the Clinical Outcome and Quality of Life in Chinese Post-operative CRSwNP Patients
- Record updated
- 25 September 2026